Literature DB >> 2035624

Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources.

H Yki-Järvinen1, I Puhakainen, C Saloranta, L Groop, M R Taskinen.   

Abstract

We examined the regulation of intracellular and intravascular lipolysis in vivo. In the first series of studies, plasma free fatty acids (FFA) were elevated moderately by heparin (plus approximately 600 mumol/l) in patients with non-insulin-dependent diabetes mellitus (NIDDM) and in normal subjects. The increase in plasma FFA increased plasma FFA oxidation "submaximally" (plasma FFA oxidation less than 100% of total lipid oxidation) in a plasma FFA concentration-dependent manner. The increase in plasma FFA oxidation significantly suppressed direct intracellular oxidation of FFA. In another group of patients with NIDDM, plasma FFA was markedly increased (plus approximately 1,500 mumol/l). Plasma FFA oxidation now accounted for all lipid oxidation. Compared with substrate oxidation rates observed at submaximally elevated plasma FFAs in the same subjects at similar insulin concentrations, total lipid oxidation increased, carbohydrate oxidation decreased, and total energy production increased. These data demonstrate the existence of an FFA-dependent insulin-independent feedback mechanism between FFA oxidation from intracellular and intravascular sources. Thus the preferred response of body tissues to a change in plasma FFA oxidation is a reciprocal change in direct intracellular FFA oxidation. Substrate competition between carbohydrate and lipid, as proposed by P. J. Randle et al. (Lancet 1:785, 1963), becomes operative after the capacity for regulation within components of lipid oxidation has been utilized.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035624     DOI: 10.1152/ajpendo.1991.260.5.E680

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease.

Authors:  Panu K Luukkonen; Taru Tukiainen; Anne Juuti; Henna Sammalkorpi; P A Nidhina Haridas; Onni Niemelä; Johanna Arola; Marju Orho-Melander; Antti Hakkarainen; Petri T Kovanen; Om Dwivedi; Leif Groop; Leanne Hodson; Amalia Gastaldelli; Tuulia Hyötyläinen; Matej Orešič; Hannele Yki-Järvinen
Journal:  JCI Insight       Date:  2020-03-12

2.  Mechanism of free fatty acid-induced insulin resistance in humans.

Authors:  M Roden; T B Price; G Perseghin; K F Petersen; D L Rothman; G W Cline; G I Shulman
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

3.  Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.

Authors:  P Nuutila; V A Koivisto; J Knuuti; U Ruotsalainen; M Teräs; M Haaparanta; J Bergman; O Solin; L M Voipio-Pulkki; U Wegelius
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

4.  Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in type 2 (non-insulin-dependent) diabetic patients.

Authors:  H Vuorinen-Markkola; H Yki-Järvinen; M R Taskinen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

5.  Pathway of free fatty acid oxidation in human subjects. Implications for tracer studies.

Authors:  L S Sidossis; A R Coggan; A Gastaldelli; R R Wolfe
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

6.  Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.

Authors:  G Boden; X Chen
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 7.  Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome.

Authors:  Cristina Lara-Castro; W Timothy Garvey
Journal:  Endocrinol Metab Clin North Am       Date:  2008-12       Impact factor: 4.741

8.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity.

Authors:  A Dresner; D Laurent; M Marcucci; M E Griffin; S Dufour; G W Cline; L A Slezak; D K Andersen; R S Hundal; D L Rothman; K F Petersen; G I Shulman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo.

Authors:  Faidon Magkos; Bettina Mittendorfer
Journal:  Clin Lipidol       Date:  2009-04-01

10.  Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.

Authors:  Panu K Luukkonen; Sanja Sädevirta; You Zhou; Brandon Kayser; Ashfaq Ali; Linda Ahonen; Susanna Lallukka; Véronique Pelloux; Melania Gaggini; Ching Jian; Antti Hakkarainen; Nina Lundbom; Helena Gylling; Anne Salonen; Matej Orešič; Tuulia Hyötyläinen; Marju Orho-Melander; Aila Rissanen; Amalia Gastaldelli; Karine Clément; Leanne Hodson; Hannele Yki-Järvinen
Journal:  Diabetes Care       Date:  2018-05-29       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.